Loading data
ELDNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 66.27 m USD | 51.96 m USD | 30.31 m USD | 27.08 m USD | 23.74 m USD |
| Operating profit | — | — | -43 m USD | -88.43 m USD | -36.87 m USD |
| Profit before tax | -45.58 m USD | -35.75 m USD | -116.54 m USD | -87.97 m USD | -36.86 m USD |
| Income tax expense | 35 k USD | 431 k USD | 0 USD | 0 USD | -2.35 m USD |
| Net income (reported basis) | -45.62 m USD | -36.18 m USD | -116.54 m USD | -87.97 m USD | -34.51 m USD |
| Net income attributable to common shareholders | -42.33 m USD | -31.99 m USD | — | — | — |
| Basic earnings per share | -0.52 USD/share | -0.66 USD/share | -4.73 USD/share | -6.16 USD/share | -2.33 USD/share |
| Diluted earnings per share | -0.52 USD/share | -0.66 USD/share | -4.73 USD/share | -6.16 USD/share | -2.33 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.